Imperagen
PrivateLast Round
Seed
May 21, 2026
Total Funding Raised
$17.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Imperagen is a biotechnology company that provides a digital enzyme evolution platform to accelerate enzyme engineering for the pharmaceutical and chemical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imperagen Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Imperagen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 21, 2026 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Mar 14, 2024 | ||||
| Seed | Aug 2, 2022 |
Key People
Founding team and executive leadership
Imperagen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IQ Capital | Seed |
| Innovate UK | Grant |
| Northern Gritstone | Seed |
| PXN Ventures | Seed |
| PXN Group | Seed |
| PXN Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
$5M round led by PXN Group
- Jan 21, 2026
Grew 20% QoQ from 15 to 18 employees.
Imperagen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imperagen's valuation, stock price, and market status.